Item 1.01 Entry Into A Material Definitive Agreement.
Business Combination Agreement
On September 30, 2022 (Hong Kong Time)/September 29, 2022 (Eastern Time), Magnum
Opus Acquisition Limited, a Cayman Islands exempted company (the "SPAC"),
entered into an Agreement and Plan of Merger (the "Business Combination
Agreement") with Asia Innovations Group Limited., a Cayman Islands exempted
company ("ASIG") and Connect Merger Sub, a Cayman Islands exempted company and a
wholly-owned subsidiary of the Company (the "Merger Sub"), which provides for
the Merger (as defined below) and other transactions in connection therewith
(collectively, the "Business Combination"). The time of the closing of the
Merger is referred to herein as the "Closing." The date of the Closing of the
Merger is referred to herein as the "Closing Date." Capitalized terms used but
not defined herein shall have the meanings ascribed to them in the Business
Combination Agreement.
The Business Combination Agreement and the transactions contemplated thereby
were unanimously approved by the board of directors of the SPAC.
The Business Combination and Consideration
Subject to, and in accordance with, the terms and conditions of the Business
Combination Agreement, among other things, (i) on the Closing Date immediately
prior to the Effective Time, all Amended 2020 Convertible Notes, Amended 2021
Convertible Notes, 2022 Convertible Notes, and 2022 Major Investor Convertible
Notes (to the extent holders of such 2022 Major Investor Convertible Notes elect
to so convert) that are outstanding shall be converted into Company
Pre-Subdivision Ordinary Shares (par value $0.00001 per share) in accordance
with the respective terms and conditions therein, (ii) each outstanding Company
Pre-Subdivision Ordinary Share and Company Pre-Subdivision Preferred Share
(other than such shares held by Key Executives) shall be subdivided into such
number Company Class A Ordinary Shares equal to the Subdivision Factor and
re-designated as Company Class A Ordinary Shares if applicable, (iii) each
outstanding Company Pre-Subdivision Ordinary Share and Company Pre-Subdivision
Preferred Share held by Key Executives shall be subdivided into such number of
Company Class B Ordinary Shares equal to the Subdivision Factor and
re-designated as Company Class B Ordinary Shares if applicable, (iv) the CEHK
Warrant shall be amended to provide that the amended CEHK Warrant is exercisable
for a number of Company Class A Ordinary Shares pursuant to the terms therein
and (v) each Company Option, Key Executive Option, Company RSU and Key Executive
RSU shall be converted pursuant to the terms of the Business Combination
Agreement (items (i) through (v), the "Recapitalization").
Pursuant to the Business Combination Agreement, immediately prior to the
Effective Time, each SPAC Class B Share shall be automatically converted into
one (1) SPAC Class A Share (par value $0.0001 per share). Immediately prior to
the Effective Time, the SPAC Class A Shares and the SPAC Public Warrants
comprising each issued and outstanding unit of the SPAC ("SPAC Unit"),
consisting of one (1) SPAC Class A Share and one-half (1/2) of one (1) SPAC
Public Warrant, will be automatically separated ("Unit Separation") and the
holder thereof will be deemed to hold one (1) SPAC Class A Share and one-half
(1/2) of one (1) SPAC Public Warrant. No fractional SPAC Public Warrants will be
issued in connection with the Unit Separation such that if a holder of such SPAC
Units would be entitled to receive a fractional SPAC Public Warrant upon such
separation, the number of SPAC Public Warrants to be issued to such holder upon
such separation will be rounded down to the nearest whole number of SPAC Public
Warrants and no cash will be paid in lieu of such fractional SPAC Public
Warrants.
Subject to, and in accordance with, the terms and conditions of the Business
Combination Agreement, on the Closing Date and immediately prior to the
Effective Time, (i) each issued and outstanding SPAC Class A Share shall be
converted automatically into the right of the holder thereof to receive one
Company Class A Ordinary Share after giving effect to the Recapitalization, and
(ii) each issued and outstanding SPAC Warrant (including the SPAC Public
Warrants held as a result of the Unit Separation) sold to the public and to
Magnum Opus Holdings LLC, a Cayman Islands limited liability company
("Sponsor"), in a private placement in connection with the SPAC's initial public
offering will be automatically converted into one (1) Company Warrant
exercisable for Company Class A Ordinary shares in accordance with its terms. At
the Closing, in accordance with the Companies Act (as revised) of the Cayman
Islands, Merger Sub will merge with and into the SPAC, the separate corporate
existence of Merger Sub will cease and the SPAC will be the surviving
corporation and a wholly-owned subsidiary of ASIG (the "Merger").
The "Subdivision Factor" is a number resulting from dividing (i) the result of
(x) $2,500,000,000 minus (y) the Convertible Notes Adjustment Amount, divided by
(z) $10.00, minus (y) the aggregate number of SPAC Class A Shares entitled to
receive Merger Consideration pursuant to the Business Combination Agreement at
Closing (assuming for these purposes that the SPAC Class B Conversion, as may be
modified by the Sponsor Support Agreement, has already occurred), by (ii) the
Aggregate Fully Diluted Company Shares, and (y) $10.00. The "Aggregate Fully
Diluted Company Shares" means, without duplication as of immediately prior to
the Share Subdivision, the sum of (a) the aggregate number of Pre-Subdivision
Shares that are issued and outstanding, excluding (1) all Pre-Subdivision Shares
held by the trust established for ASIG's share incentive plan which have not
been allocated to or otherwise do not correspond to any issued and outstanding
restricted share unit of ASIG and (2) any Pre-Subdivision Shares or restricted
share units of ASIG that may be issued in connection with investments and
acquisitions that ASIG is permitted to make following the date of the Business
Combination Agreement but before the Closing under the Business Combination
Agreement, and (b) the aggregate number of Pre-Subdivision Shares that are
issuable upon the exercise, exchange or conversion of all outstanding Company
Convertible Securities or that are issuable in connection with any Transaction
Financing.
Representations and Warranties; Covenants
The parties to the Business Combination Agreement have agreed to customary
representations and warranties for transactions of this type. The
representations and warranties made under the Business Combination Agreement
will not survive the Closing.
In addition, the parties to the Business Combination Agreement agreed to be
bound by certain customary covenants for transactions of this type, including,
among others, (i) a covenant of each party to use its reasonable best efforts to
cause the Business Combination to be consummated after the date of the Business
Combination Agreement as promptly as reasonably practicable, (ii) a covenant of
the SPAC to convene an extraordinary general meeting of the SPAC and of the
board of directors of the SPAC to recommend that the shareholders of the SPAC
approve the shareholder proposals, except that the board of directors of the
SPAC may postpone or adjourn such extraordinary general meeting to comply with
applicable law, to ensure that any supplement or amendment to the proxy
statement is required under applicable law to be disseminated to the SPAC
shareholders, if there are insufficient SPAC shares represented to constitute a
quorum and in order to seek withdrawals from redemption requests if this will
cause the sum of (x) amount of cash in the trust account (after taking into
account the redemption by SPAC shareholders) and (y) proceeds from the
Transaction Financing to fall below $150,000,000, (iii) covenants providing that
the parties will not solicit, initiate, encourage or continue discussions with
respect to any other Alternative Transaction Proposal, (iv) a covenant by ASIG
to deliver to the SPAC the audited financial statements that have been prepared
in accordance with PCAOB auditing standards by a PCAOB qualified auditor and
other audited financial statements of ASIG that are required to be included in
the proxy statement, and (v) a covenant by the SPAC that in the event that the
Merger is not consummated by February 1, 2023 and it is reasonably determined by
ASIG and the SPAC that is reasonably likely that the Merger will not be
consummated by March 25, 2023, the SPAC shall (with ASIG's reasonable
cooperation) use reasonable best efforts to file a proxy statement and to amend
the organization documents of the SPAC in order to extend the date by which the
SPAC must consummate the Merger in accordance with its organization documents.
Conditions to Each Party's Obligations
Under the Business Combination Agreement, the obligations of the parties (or, in
some cases, some of the parties) to consummate the Merger are subject to the
satisfaction or waiver of certain customary closing conditions of the respective
parties, including, among others, (i) the accuracy of representations and
warranties to various standards, from no material qualifier to a material
adverse effect qualifier, (ii) material compliance with pre-closing covenants,
(iii) no material adverse effect both for the SPAC and ASIG and its
subsidiaries, (iv) the delivery of customary closing certificates, (v) receipt
of all consents from Competition Authorities, (vi) the absence of a legal
prohibition on consummating the transactions, (vii) approval by the SPAC's and
ASIG's shareholders, (viii) approval of a listing application on the NYSE for
newly issued shares, and (ix) the SPAC having at least US$5,000,001 of net
tangible assets remaining after redemption. ASIG's obligation to consummate the
Merger is also subject to the amount of available cash of the SPAC from a
combination of the SPAC's trust account and Transaction Financing being no less
than $150,000,000.
Transaction Financing
As promptly as reasonably practicable after the execution of the Business
Combination Agreement, the SPAC and ASIG shall use reasonable best efforts to
enter into subscription agreements with certain investors (the "Transaction
Financing Investors"), pursuant to which the Transaction Financing Investors
commit to purchase Equity Securities of ASIG, with the form of such Equity
Securities of ASIG to be agreed by the SPAC and ASIG in the aggregate amount of
$150,000,000 (the "Transaction Financing"). The Transaction Financing shall be
consummated within ninety (90) days after the date of the Business Combination
Agreement.
Termination
The Business Combination Agreement may be terminated under certain customary and
limited circumstances at any time prior to the closing of the Merger, including,
among things, (i) by mutual written consent of the SPAC and ASIG, (ii) upon any
permanent injunction or other governmental order preventing the consummation of
the transactions which shall have become final and non-appealable, (iii) upon a
material breach of any representation, warranty, covenant or agreement (subject
to an opportunity to cure, if such violation or breach is capable of being
cured) and (iv) if the Merger has not been consummated by the first anniversary
of the date of the Business Combination Agreement and such failure in closing
beyond such date is not primarily due to the breach of the Business Combination
Agreement by the party seeking to terminate.
The foregoing description of the Business Combination Agreement and the Business
Combination does not purport to be complete and is qualified in its entirety by
the terms and conditions of the Business Combination Agreement, a copy of which
is attached hereto as Exhibit 2.1 and is incorporated herein by reference. The
Business Combination Agreement contains representations, warranties and
covenants that the respective parties made to each other as of the date of such
agreement or other specific dates. The assertions embodied in those
representations, warranties and covenants were made for purposes of the contract
among the respective parties and are subject to important qualifications and
limitations agreed to by the parties in connection with negotiating the Business
Combination Agreement. The Business Combination Agreement has been included to
provide investors with information regarding its terms. It is not intended to
provide any other factual information about the parties to the Business
Combination Agreement. In particular, the representations, warranties, covenants
and agreements contained in the Business Combination Agreement, which were made
only for purposes of the Business Combination Agreement and as of specific
dates, were solely for the benefit of the parties to the Business Combination
Agreement, may be subject to limitations agreed upon by the contracting parties
(including being qualified by confidential disclosures made for the purposes of
allocating contractual risk between the parties to the Business Combination
Agreement instead of establishing these matters as facts) and may be subject to
standards of materiality applicable to the contracting parties that differ from
those applicable to investors and reports and documents filed with the U.S.
Securities and Exchange Commission (the "SEC"). Investors should not rely on the
representations, warranties, covenants and agreements, or any descriptions
thereof, as characterizations of the actual state of facts or condition of any
party to the Business Combination Agreement. In addition, the representations,
warranties, covenants and agreements and other terms of the Business Combination
Agreement may be subject to subsequent waiver or modification. Moreover,
information concerning the subject matter of the representations and warranties
and other terms may change after the date of the Business Combination Agreement,
which subsequent information may or may not be fully reflected in the SPAC's
public disclosures.
Other Agreements
The Business Combination Agreement contemplates the execution of various
additional agreements and instruments, on or before the Closing, including,
among others, the following:
Sponsor Lock-Up and Support Agreement
Concurrently with the execution of the Business Combination Agreement, the SPAC,
the Sponsor, certain directors and officers of the SPAC listed thereto (together
with the Sponsor, each a "SPAC Shareholder") and ASIG entered into a sponsor
. . .
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
2.1* Agreement and Plan of Merger, dated as of September 30, 2022 (Hong
Kong Time)/September 29, 2022 (Eastern Time), by and among Magnum Opus
Acquisition Limited, Asia Innovations Group Limited, and Connect Merger
Sub.
10.1* Sponsor Lock-Up and Support Agreement, dated as of September 30, 2022
(Hong Kong Time)/September 29, 2022 (Eastern Time), by and among Magnum
Opus Acquisition Limited, Asia Innovations Group Limited, Magnum Opus
Holdings LLC, and certain shareholders of Magnum Opus Acquisition
Limited.
10.2* Company Shareholder Voting Agreement, dated as of September 30, 2022
(Hong Kong Time)/September 29, 2022 (Eastern Time), by and among Magnum
Opus Acquisition Limited, Asia Innovations Group Limited, and certain
shareholders of Asia Innovations Group Limited.
10.3 Form of Registration Rights Agreement by and among Asia Innovations
Group Limited, Magnum Opus Holdings LLC and certain other parties
thereto.
10.4 Form of Assignment and Assumption Agreement by and among Magnum Opus
Acquisition Limited, Asia Innovations Group Limited and Continental
Stock Transfer & Trust Company.
* The schedules to this Exhibit have been omitted in accordance with Regulation
S-K Item 601(b)(2). The SPAC hereby undertakes to furnish supplementally a copy
of any omitted schedule to the SEC upon its request; provided, however, that the
SPAC may request confidential treatment for any such schedules so furnished.
© Edgar Online, source Glimpses